Skip to main content

Table 2 Data collected from the CGM device and 7-day diary of the participants

From: Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia

GROUPS (all participants Caucasian)Group 1 N = 54
glucose > 3.9 mmol/L
Group 2 N = 25
glucose 3.9–3 mmol/L
Group 3 N = 15
glucose < 3.0 mmol/L
Pairwise comparison (p value)
 MedianSDMedianSDMedianSDGroup 1 vs. Group 2Group 1 vs. Group 3Group 2 vs. Group 3
Physical activity (minutes)30.0028.0230.0036.2660.0031.670.050.020.33
Sensor glucose (mmol/l)6.801.335.800.526.101.010.000.020.03
GMI44.706.2740.002.4541.424.730.000.020.03
CV%41.0010.3233.539.2925.524.750.010.000.00
SD1.800.591.600.472.400.380.010.000.00
  1. GMI Glucose management indicator, %CV Percentage coefficient of variation for glucose levels, SD standard deviation